231 related articles for article (PubMed ID: 4337205)
21. The kissing virus.
Haire M
Ulster Med J; 1981; 50(1):1-9. PubMed ID: 6262973
[No Abstract] [Full Text] [Related]
22. Biological properties of the Epstein-Barr virus and its possible role in human malignancy.
Glaser R; Rapp F
Prog Med Virol; 1975; 21():43-57. PubMed ID: 174156
[No Abstract] [Full Text] [Related]
23. The sero-epidemiology of Epstein-Barr virus.
Henle W; Henle G
Adv Pathobiol; 1976; (5):5-17. PubMed ID: 220858
[No Abstract] [Full Text] [Related]
24. Evidence for an oncogenic potential of the Epstein-Barr virus.
Henle W; Henle G
Cancer Res; 1973 Jun; 33(6):1419-23. PubMed ID: 4352376
[No Abstract] [Full Text] [Related]
25. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
26. The Epstein-Barr virus: historical, biologic, pathologic and oncologic considerations.
Seemayer TA; Oligny LL; Gartner JG
Perspect Pediatr Pathol; 1981; 6():1-33. PubMed ID: 6275338
[No Abstract] [Full Text] [Related]
27. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
Pearson G; Dewey F; Klein G; Henle G; Henle W
J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
[TBL] [Abstract][Full Text] [Related]
28. Clinical syndromes associated with EB virus infection.
Evans AS
Adv Intern Med; 1972; 18():77-93. PubMed ID: 4351197
[No Abstract] [Full Text] [Related]
29. Epstein-Barr virus and human malignancy.
Ziegler JL; Magrath IT; Gerber P; Levine PH
Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930
[TBL] [Abstract][Full Text] [Related]
30. [Immunological aspects in experimental oncology].
Thiele HG
Munch Med Wochenschr; 1971 Mar; 113(10):333-8. PubMed ID: 4323333
[No Abstract] [Full Text] [Related]
31. The Epstein-Barr virus and neoplasia.
Klein G
N Engl J Med; 1975 Dec; 293(26):1353-7. PubMed ID: 171578
[No Abstract] [Full Text] [Related]
32. Antigens of virus-induced tumors.
Habel K
Adv Immunol; 1969; 10():229-50. PubMed ID: 4311886
[No Abstract] [Full Text] [Related]
33. The Epstein-Barr virus.
Henle W; Henle G; Lennette ET
Sci Am; 1979 Jul; 241(1):48-59. PubMed ID: 221971
[No Abstract] [Full Text] [Related]
34. Epstein-Barr virus infection in relation to infectious mononucleosis and Burkitt's lymphoma.
Smith RT; Bausher JC
Annu Rev Med; 1972; 23():39-56. PubMed ID: 4345525
[No Abstract] [Full Text] [Related]
35. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
Banatvala JE; Best JM; Waller DK
Lancet; 1972 Jun; 1(7762):1205-8. PubMed ID: 4113190
[No Abstract] [Full Text] [Related]
36. [Seroepidemiology of Epstein-Barr virus].
Pannuti CS
Rev Saude Publica; 1981 Feb; 15(1):93-100. PubMed ID: 6275491
[No Abstract] [Full Text] [Related]
37. [Present status of infectious mononucleosis and Epstein Barr virus].
Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
[No Abstract] [Full Text] [Related]
38. [Problems posed by the immunological properties common to Burkitt's lymphoma and cancer. Means of resolving them].
De-Thé G
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):767-88. PubMed ID: 4340546
[No Abstract] [Full Text] [Related]
39. Herpes viruses and oncogenesis.
Klein G
Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
[No Abstract] [Full Text] [Related]
40. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
